Tata Capital Healthcare Fund II deploys USD 124 million of fund corpus

New Delhi: Tata Capital Healthcare Fund unveiled its FY25 Impact & ESG Report, showcasing strong momentum in advancing access to affordable, high-quality healthcare and life sciences value chain ecosystem in India, alongside driving measurable environmental, social, and governance (ESG) outcomes.

The report noted that Tata Capital Healthcare Fund II (TCHF II) has deployed USD 124 million, nearly 95% of its ~USD 130 million corpus across its portfolio including pharmaceuticals, healthcare delivery, health-tech and MedTech services, reflecting a diversified approach to building sustainable healthcare ecosystems. Together, TCHF I and II have raised over USD 200 million, reflecting sustained investor confidence and long-term impact. 

Commenting on the Impact Report 2025, Visalakshi Chandramouli, Managing Partner, Tata Capital Healthcare Fund II, said, “As a deep-impact investor, Tata Capital Healthcare Fund (TCHF) remains committed to building resilient healthcare systems and value chains, backing-innovative business models and expanding access to affordable and quality healthcare at the last-mile.” She further added, “Our CARES framework, which stands for Coverage, Access to Work, Responsible Investing, Equity, and Sustainability, ensures ESG is embedded across our investments. We continue to drive responsible growth and measurable impact across our portfolio.”

The FY25 Impact Report records 8.3 million direct health beneficiaries, reflecting 10% year-on-year growth, along with 55 jobs created per USD 1 million invested. It also notes a 31% rise in women employees, with women now forming 24% of the portfolio workforce, reinforcing the fund’s emphasis on inclusion and equitable growth.

The report observed that an aging population, a rising chronic disease burden, and increasing demand for value-based care are strengthening the case for sustained healthcare investment. In India, where a large share of healthcare spending remains out-of-pocket, TCHF is prioritizing investments that expand access to high-quality, affordable care.

In FY25, the fund’s portfolio companies operated 332 healthcare facilities and delivered 608 million+ products and services across India, addressing critical healthcare gaps across the country. Tata Capital Healthcare Fund II has so far invested in 10 companies spanning diverse healthcare segments. These include Linux Laboratories, Sakar Healthcare, Orbicular Pharma, Atulaya Healthcare, Anderson Diagnostics, Deeptek, Apex Kidney Care, Mumbai Oncocare Centre, Noble Plus Pharmacy and Harsoria.